moexipril has been researched along with Menopause in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ivleva, AIa | 1 |
| Chen, Y; Jee, WS; Ma, Y; Stimpel, M; Yamamoto, N | 1 |
2 other study(ies) available for moexipril and Menopause
| Article | Year |
|---|---|
[Investigation of efficacy of cardiovascular drugs in women].
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Disease; Drug Prescriptions; Female; Humans; Hypertension; Hypolipidemic Agents; Male; Menopause; Sex Distribution; Tetrahydroisoquinolines; Treatment Outcome | 2006 |
Impact of antihypertensive therapy on postmenopausal osteoporosis: effects of the angiotensin converting enzyme inhibitor moexipril, 17beta-estradiol and their combination on the ovariectomy-induced cancellous bone loss in young rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Drug Therapy, Combination; Estradiol; Female; Hypertension; Isoquinolines; Menopause; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Tibia | 1995 |